Navigation Links
Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
Date:9/16/2009

EAST RUTHERFORD, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) announced today that its Continuous-Flow Microwave-Assisted Organic Synthesis (CF-MAOS) technology has been accepted as a nominee for the 2009 Innovations Awards at CPhI, an important upcoming pharmaceutical ingredients exhibition to be held in Madrid, Spain.

The CF-MAOS technology represents a dual technological breakthrough, allowing both the scale-up of microwave-assisted chemistry and the handling of heterogeneous mixtures in continuous-flow. This new technology will finally bring the benefits of both technologies out of the laboratory and into production. The CaMWave(TM) KiloLAB flow reactor is capable of manufacturing in excess of 20 kilograms of product per day, and combined with larger reactors, can generate more than one hundred metric tons of product per year. This versatile technology facilitates faster, cleaner, more reliable reactions, leading to improved productivity and lower manufacturing costs.


    The technology will be presented during the CPhI Innovation Awards:

    Title:        Microwave Chemistry - Out of the Lab and Into Production
    Speaker:      Dr. Jayne E. Muir
    Date:         October 13, 2009
    Location:     Hall 10, Stand 10G16
    Time:         11:00-11:20 a.m.

    Visit Cambrex at CPhI in Madrid at Feria de Madrid Hall 3, Stand 3C70 on
    October 13-15, 2009.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceutic
'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
2. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex Reports Third Quarter 2008 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports First Quarter 2009 Results
7. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
8. Directed self-ordering of organic molecules for electronic devices
9. SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing
10. Sigma-Aldrich Signs Agreement With Plextronics to Distribute Plexcore(R) Organic Electronics Materials
11. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... July 1, 2015 R-Japan Co.,Ltd. obtained the license ... of Regenerative Medicine from the Ministry of Health, Labour and ... 2015. The fact that R- Japan ... the auditing from Pharmaceuticals and Medical Devices Agency (PMDA) on ... it to provide stem cell manufacturing service to medical institutions. ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
(Date:6/30/2015)... June 30, 2015  NASA astronaut Kjell Lindgren , ... on his first mission to the International Space Station ... to 9 a.m. EDT Tuesday, July 7. Lindgren ... City, Russia . The interviews will be ... highlighting his mission training. To schedule an interview, ...
(Date:6/30/2015)... , June 30, 2015  Today, Americord Registry, one ... announced Andrew Horne , a partner at Kirkland & ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   ... Americord,s Advisory Board," says Martin Smithmyer , CEO of ... his legal career that will assist Americord,s growth and vision." ...
Breaking Biology Technology:R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Americord Registry Announces Andrew Horne as Advisory Board Member 2
... campaign season, and you've been poked and prodded by television ... John Kerry drank a beer at your neighborhood bar and ... Dick Cheney was spotted more in Wisconsin in 2004 than ... years. John Edwards has been in the state so often ...
... studies stem cells in his Primate Center lab. Photo ... Wis. James Thomson avoided talking ... the presidential election, explaining instead the science behind his ... on the University of Wisconsin-Madison campus since his 1998 ...
... Silicon Graphics Inc. Chippewa Valley, Wis. — ... in about 129 days, and it was the company's Chippewa ... the completion of the $50 million project for NASA ... space shuttle that crashed last year, runs on SGIs ...
Cached Biology Technology:Twenty ways you can tell this campaign has finally pushed you over the edge 2James Thomson plans to stay in Madison to study genesis of stem cells 2James Thomson plans to stay in Madison to study genesis of stem cells 3SGIs Wisconsin branch builds fastest supercomputer yet in four months 2
(Date:6/11/2015)... 2015 Daon, a global leader in ... IdentityX Mobile Authentication Platform v4.0 has been FIDO ... an industry consortium launched in 2013 to revolutionize ... authentication.  In order to receive certification, a company,s ... of tests that measure compliance and ensure interoperability ...
(Date:6/9/2015)... , June 09, 2015 Research ... addition of the "Gesture Recognition & Touchless ... (Consumer Electronics, Automotive, & Others), Product (Biometric & ... to 2020" report to their offering. ... market is expected to reach $ 23.55 Billion ...
(Date:6/5/2015)... Md. , June 5, 2015  Intrexon Corporation ... biology, today announced that it has determined the final ... all of its 17,830,305 shares of ZIOPHARM Oncology, Inc. ... about June 12, 2015, the distribution date, as a ... and on warrants to purchase shares of Intrexon common ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4
... 3, 2009 -- Despite the striking aromatic differences between ... nose,s neural circuitry suggests a haphazard patchwork where the ... not to be neighbors. Inexplicably, this seemingly random ... with cells that process the same scent located in ...
... the Swiss National Center of Competence in Research in ... to predict how breast cancer patients respond to chemotherapy, ... the future. In an article, ,A stroma-related gene signature ... published in Nature Medicine , Dr Pierre Farmer ...
... automobile, even during an economic downturn. Every day, hundreds ... remote places, to commute, and to reach the supermarket. ... trillions of dollars and millions of worker-hours. Miklos Szilagyi ... an apparent waste of resources, a serious producer of ...
Cached Biology News:Neural mapping paints a haphazard picture of odor receptors 2Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer 2Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer 3Defectors take the car, cooperators go by bus 2
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
Mouse polyclonal antibody raised against a partial recombinant CD320. NCBI Entrez Gene ID = 51293...
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Biology Products: